Can virtual patients predict whether a drug will succeed? Phase Advance is using mechanistic virtual patient models to predict how LEAF4Life's hypoxia-targeting therapy could perform across multiple indications. Written byBree Foster, PhD

Can virtual patients predict whether a drug will succeed? Phase Advance is using mechanistic virtual patient models to predict how LEAF4Life's hypoxia-targeting therapy could perform across multiple indications. Written byBree Foster, PhD https://www.drugdiscoverynews.com/can-virtual-patients-predict-whether-a-drug-will-succeed-17347?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-8s57svN6Mo4YAkrHnHI5ITZbWDJs8HiJRiXUti_32xUw9yxJ5T6K6Smz82PyyP_hDHSN41_C-SqslS1_xw0tAxA9QQ9A&_hsmi=429665426&utm_content=429665426&utm_source=hs_email